SEC Form D · Amendment · filed April 20, 2017
Velicept Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Paul Abelow · Morganville, NJDirectorJohn Shields · Wakefield, MAExec · DirectorDawn A. Cummings · Grand Cayman, Cayman IslandsDirectorJames Bennethum · Gaylord, MIDirectorSunil K. Gottipati · Princeton, NJDirectorDavid Hirsch · Greenwich, CTDirectorDouglas Gessl · Malvern, PAExecScott Morenstein · New York, NYDirectorStephen Tullman · Malvern, PADirectorI. R. Garr · Germantown, MDExecJohn Giordano · Wakefield, MADirectorTiffany Freitas · Wakefield, MADirectorAmir Haleem · San Francisco, CAExec · DirectorJames Walker · Malvern, PAExec · DirectorDave Blundin · Wakefield, MADirectorLikai C. Lin · Boston, MADirectorStanley R. Westreich · Germantown, MDExecGregory A. Ellis · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗